Top of this page
Skip navigation, go straight to the content

Our Company

Disease Areas

Our Science

UCB Worldwide

 Search

Our Products

Newsroom

Patients

Investors

HCP

Clinical Studies

Advantage Hers

FOLLOW US ON
© 2007 – 2021 UCB S.A., Belgium. All rights reserved.
This section is intended for media and financial analysts
Newsroom • Press Releases

Search Press releases


Disposals of own shares05 May 2021

Disposals of own shares

Read more
UCB's General Meeting of Shareholders 202129 Apr 2021

UCB's General Meeting of Shareholders 2021

Read more
UCB Announces PDUFA Date for Bimekizumab28 Apr 2021

UCB Announces PDUFA Date for Bimekizumab

Read more
Acquisitions of own shares and disposals of own shares23 Apr 2021

Acquisitions of own shares and disposals of own shares

Read more
UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 202123 Apr 2021

UCB to Present 12 Abstracts on Bimekizumab at AAD VMX 2021

Read more
The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis23 Apr 2021

The New England Journal of Medicine Publishes Results from Two …

Read more


Stay up-to-date on the latest news and information from UCB